973 — L'Occitane International SA Share Price
- HK$49.71bn
- HK$56.43bn
- €2.54bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 21.62 | ||
PEG Ratio (f) | 0.65 | ||
EPS Growth (f) | 50.36% | ||
Dividend Yield (f) | 1.57% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 6.83 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 29.8 | ||
Price to Sales | 2.3 | ||
EV to EBITDA | 16.04 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.79% | ||
Return on Equity | 9.41% | ||
Operating Margin | 9.17% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 1,644.08 | 1,537.85 | 1,781.36 | 2,134.69 | 2,541.94 | 2,908.5 | 3,247.68 | 12.24% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -1.99 | +18.88 | +63.76 | -28.07 | -31.34 | +108.39 | +26.09 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
L’OCCITANE INTERNATIONAL S.A. is a company principally engaged in the manufacture and sales of cosmetics and well-being products. Its brands include L’OCCITANE en Provence, Melvita, Le Couvent des Minimes, Erborian and L’OCCITANE en Bresil. The Company operates through three segments. Sell-out segment sells its products directly to final customers through stores and the Company’s Website. Sell-in segment sells its products to intermediates, including distributors, wholesalers, television show channels and travel retailers. The intermediates sell the products to final customers. Business to Business segment sells its products to airline companies and hotels. These airline companies and hotels provide the products as free amenities to final customers. The Company operates businesses in Japan, China, France, the United Kingdom and Russia, among others.
Directors
- Reinold Geiger CHM (73)
- Andre Hoffmann CEO (65)
- Sotaro Amano CEX (53)
- Michele Gay CEX (48)
- Nicolas Geiger CEX (40)
- Marcin Jasiak CEX (54)
- Lorenzo Giacomoni COO (52)
- Alain Buzzacaro CTO (51)
- Yves Blouin MDR (56)
- Lina Ly-Dutron MDR (49)
- Yann Tanini MDR (43)
- Aline Valatin MDR (42)
- Thomas Levilion DGM (61)
- Karl Guenard EDR (54)
- Sean Harrington EDR (55)
- Adrien Geiger OTH (36)
- Valerie Bernis NID (62)
- Charles Broadley NID (57)
- Chik Sum Ng NID (60)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- February 8th, 2001
- Public Since
- May 7th, 2010
- No. of Employees
- 9,255
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,474,968,200

- Address
- 49, Boulevard Prince Henri, LUXEMBOURG, 1724
- Web
- https://group.loccitane.com/
- Phone
- Contact
- Janis Lai
- Auditors
- PricewaterhouseCoopers Societe Cooperative
Latest News for 973
Upcoming Events for 973
Half Year 2025 L'Occitane International SA Earnings Release
Similar to 973
Anxian Yuan China Holdings
Stock Exchange of Hong Kong Limited
BaWang International Holding
Stock Exchange of Hong Kong Limited
Beauty Farm Medical & Health Industry
Stock Exchange of Hong Kong Limited
China Beststudy Education
Stock Exchange of Hong Kong Limited
BExcellent group
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:49 UTC, shares in L'Occitane International SA are trading at HK$33.70. This share price information is delayed by 15 minutes.
Shares in L'Occitane International SA last closed at HK$33.70 and the price had moved by +41.3% over the past 365 days. In terms of relative price strength the L'Occitane International SA share price has outperformed the FTSE Developed Asia Pacific Index by +25.36% over the past year.
The overall consensus recommendation for L'Occitane International SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreL'Occitane International SA does not currently pay a dividend.
L'Occitane International SA does not currently pay a dividend.
L'Occitane International SA does not currently pay a dividend.
To buy shares in L'Occitane International SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$33.70, shares in L'Occitane International SA had a market capitalisation of HK$49.71bn.
Here are the trading details for L'Occitane International SA:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 973
Based on an overall assessment of its quality, value and momentum L'Occitane International SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in L'Occitane International SA is HK$30.59. That is 9.24% below the last closing price of HK$33.70.
Analysts covering L'Occitane International SA currently have a consensus Earnings Per Share (EPS) forecast of €0.16 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like L'Occitane International SA. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +3.53%.
As of the last closing price of HK$33.70, shares in L'Occitane International SA were trading +15.87% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The L'Occitane International SA PE ratio based on its reported earnings over the past 12 months is 21.62. The shares last closed at HK$33.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
L'Occitane International SA's management team is headed by:
- Reinold Geiger - CHM
- Andre Hoffmann - CEO
- Sotaro Amano - CEX
- Michele Gay - CEX
- Nicolas Geiger - CEX
- Marcin Jasiak - CEX
- Lorenzo Giacomoni - COO
- Alain Buzzacaro - CTO
- Yves Blouin - MDR
- Lina Ly-Dutron - MDR
- Yann Tanini - MDR
- Aline Valatin - MDR
- Thomas Levilion - DGM
- Karl Guenard - EDR
- Sean Harrington - EDR
- Adrien Geiger - OTH
- Valerie Bernis - NID
- Charles Broadley - NID
- Chik Sum Ng - NID